Immuron Announces New Research Collaboration targeting Antimicrobial Resistance
Provided By GlobeNewswire
Last update: Jan 15, 2025
Highlights:
MELBOURNE, Australia, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce a new research collaboration agreement with Monash University.
Read more at globenewswire.comNASDAQ:IMRN (2/21/2025, 8:00:01 PM)
1.9
+0.01 (+0.53%)
Find more stocks in the Stock Screener
